Specific components of the tumor immune microenvironment may affect responses to BCMA CAR T-cell therapy
byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with myeloma whose tumor immune microenvironments had a more diverse baseline T-cell repertoire, fewer marker
Updated on: January 22,2024
12

Specific components of the tumor immune microenvironment may affect responses to BCMA CAR T-cell therapy
byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with myeloma whose tumor immune microenvironments had a more diverse baseline T-cell repertoire, fewer marker
Updated on:January 22,2024
12
